Mongolia vs Qatar: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Mongolia
96.0%
in 2025
Qatar
96.0%
in 2025
Mongolia rank
27th
Qatar rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Mongolia
- Qatar
How they compare
Mongolia currently reports 96.0% against 96.0% in Qatar, a difference of 0.0%.
Across all 18 years both countries report, Qatar has been ahead every year.
Mongolia ranks 27th and Qatar ranks 27th of 194 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mongolia | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.5% | 49.5% | Qatar |
| 2010s | 8.8% | 96.6% | 87.8% | Qatar |
| 2020s | 94.8% | 97.0% | 2.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Mongolia or Qatar?
- Mongolia, at 96.0% against 96.0% in Qatar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Mongolia and Qatar?
- 0.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Qatar?
- 18 years are reported by both, from 2008 to 2025.
- How do Mongolia and Qatar rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Mongolia ranks 27th and Qatar ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.